Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | ALPL | P05186 | 1/20 | 0.57 |
| ▸ | ALPI | P09923 | 1/20 | 0.57 |
| ▸ | ALPG | P10696 | 1/20 | 0.57 |
| ▸ | CA9 | Q16790 | 15/20 | 0.56 |
| ▸ | CA1 | P00915 | 13/20 | 0.56 |
| ▸ | CA2 | P00918 | 13/20 | 0.56 |
| ▸ | CA12 | O43570 | 6/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | PLEC | Q15149 | 1/20 | 0.55 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.51 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.51 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.51 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2608622 | 0.89 | USP2 (0.53) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL14173524 | 0.89 | USP2 (0.72) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL12997225 | 0.87 | USP2 (0.72) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL7973011 | 0.87 | USP2 (0.51) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL16731601 | 0.85 | USP2 (0.50) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL15369507 | 0.84 | USP2 (0.66) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL15304973 | 0.84 | USP2 (0.71) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL15369505 | 0.84 | USP2 (0.68) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL9287287 | 0.84 | USP2 (0.53) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL1437042 | 0.82 | USP2 (0.78) | USP2L3MBTL1MEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12631612-B2 | Fluorescent dye molecules for tracer applications in subterranean formations | SAUDI ARABIAN OIL COMPANY (SA) | 2026-05-19 | — | — | US | disclosed |
| US-12455285-B2 | Method for detecting bacteria according to the gram signal thereof in a complex sample | MAAT PHARMA (FR) | 2025-10-28 | — | — | US | disclosed |
| US-12440821-B2 | Method for tracing subterranean formations with oil-soluble organic molecular tracers and extracting them of from oil phases | SAUDI ARABIAN OIL COMPANY (SA) | 2025-10-14 | — | — | US | disclosed |
| CN-119954832-A | KRAS small molecule fluorescent probe and preparation method and application thereof | 中国药科大学 | 2025-05-09 | — | — | CN | disclosed |
| US-12286574-B2 | Manipulating hydrophilicity of conventional dye molecules for tracer applications | SAUDI ARABIAN OIL COMPANY (SA) | 2025-04-29 | — | — | US | disclosed |
| CN-119409674-A | Hydrolyzable fluorescent dye compound, preparation method and application thereof | 艾克发(北京)生物技术有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-118956744-A | Method and kit for capturing fetal nucleated red blood cells | 北京安琪尔基因医学科技有限公司 | 2024-11-15 | — | — | CN | disclosed |
| WO-2024220354-A1 | METHODS OF PRODUCING HIV-1 ENVELOPE GLYCOPROTEINS AND GUANOSINE MICROPARTICLES THEREOF | PUERTO RICO SCIENCE TECHNOLOGY & RESEARCH TRUST (PR) | 2024-10-24 | — | — | WO | disclosed |
| WO-2024197792-A1 | A COMPLEX COMPRISING A CELL PENETRATING PEPTIDE AND A COPI SORTING INHIBITOR AND USES THEREOF | BEIJING UNIVERSITY OF CHINESE MEDICINE (CN) | 2024-10-03 | — | — | WO | disclosed |
| US-20240269315-A1 | DRUG CONJUGATE AND USE THEREOF | BIO-THERA SOLUTIONS, LTD. (CN) | 2024-08-15 | — | — | US | disclosed |
| US-20050197634-A1 | Methods for coating and impregnating medical devices with antiseptic compositions | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2005-09-08 | — | — | US | disclosed |
| US-6927283-B2 | Modified acyl carrier proteins | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2005-08-09 | — | — | US | disclosed |
| US-20050118668-A1 | MODIFIED ACYL CARRIER PROTEINS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-06-02 | — | — | US | disclosed |
| US-20050074411-A1 | Peptide-based multimeric targeted contrast agents | EPIX MEDICAL, INC. A DELAWARE CORPORATION | 2005-04-07 | — | — | US | disclosed |
| CN-1189603-C | Fluorescent polymer cored yarn and producing method thereof | HYOSUNG CO LTD (KR) | 2005-02-16 | — | — | CN | disclosed |
| CN-1451791-A | Fluorescent polymer cored yarn and producing method thereof | HYOSUNG CO LTD (KR) | 2003-10-29 | — | — | CN | disclosed |
| US-20030198809-A1 | Fluorescent elastic yarn and method for producing the same | HYOSUNG CORPORATION (KR) | 2003-10-23 | — | — | US | disclosed |
| US-5652093-A | Analogues of reporter groups as background reducers in binding assays | APROGENEX, INC. (US) | 1997-07-29 | — | — | US | disclosed |
| US-5501952-A | Analogues of reporter groups as background reducers in hybridization assays | APROGENEX, INC. (US) | 1996-03-26 | — | — | US | disclosed |
| WO-1995002699-A1 | ANALOGUES OF REPORTER GROUPS AS BACKGROUNG REDUCERS IN HYBRIDIZATION ASSAYS | APROGENEX, INC. (US) | 1995-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12631612-B2 | Fluorescent dye molecules for tracer applications in subterranean formations | CD99, TST, TDO2 | USP2 4597/4885L3MBTL1 2148/4885MEN1 3536/4885 |
| US-20050074411-A1 | Peptide-based multimeric targeted contrast agents | NGLY1, IAPP, NPPA | USP2 1598/4885L3MBTL1 1784/4885MEN1 41/4885 |
| US-20240269315-A1 | DRUG CONJUGATE AND USE THEREOF | CD47, SLC10A1, SSB | USP2 3736/4885L3MBTL1 2461/4885MEN1 326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.